EcoDrugPlus

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSSAUG00010014229
Gene Symbol: MTOR
1 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSSAUG00010008684
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSSAUG00010024018
Gene Symbol: LOC115569611
3 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSSAUG00010025513
Gene Symbol: MTNR1A
3 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSSAUG00010005025
Gene Symbol: MME
1 Cross references
231 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSSAUG00010000316
Gene Symbol: LOC115583464
3 Cross references
206 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSSAUG00010009859
Gene Symbol: LOC115586660
3 Cross references
215 Possible Orthologues:

Methionyl Aminopeptidase 2b

Ensembl ID : ENSSAUG00010018160
Gene Symbol: METAP2B
1 Cross references
220 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSSAUG00010005040
Gene Symbol: MAPK1
3 Cross references
209 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSSAUG00010010043
Gene Symbol: MAPK10
1 Cross references
88 Possible Orthologues:

Mitogen-Activated Protein Kinase 11-Like

Ensembl ID : ENSSAUG00010025462
Gene Symbol: LOC115595512
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSSAUG00010025761
Gene Symbol: MAPK14
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).